T2 Biosystems Inc (FRA:3T2)
€ 4.06 -0.15 (-3.56%) Market Cap: 67.24 Mil Enterprise Value: 106.99 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 34/100

T2 Biosystems Inc Annual Shareholders Meeting Transcript

Aug 06, 2020 / 01:00PM GMT
Release Date Price: €145.1 (+2.87%)
Operator

Hello, ladies and gentlemen, thank you for standing by. And welcome to the T2 Biosystems, Inc. Annual Meeting. (Operator Instructions) I would now like to hand the conference over to your speaker today, Michael Gibbs. Thank you. Please go ahead, sir.

Michael Terrence Gibbs
T2 Biosystems, Inc. - VP, General Counsel & Corporate Secretary

Welcome, everyone, to the 2020 annual meeting of stockholders of T2 Biosystems. My name is Mike Gibbs, and I'm the General Counsel and Secretary of the company, and I will be acting as Secretary of this meeting. Based upon the proxies received prior to this meeting, a quorum is present, and I declare this meeting to be duly convened for purposes of transacting such business as may properly come before. Before I go any further, I would like to introduce several of the company's officials who are here today. As directors of the company, we have present, John McDonough, Chairman of the Board; Jack Cumming, Lead Independent Director; John Sperzel, CEO and President; David Elsbree; Seymour Liebman; Robin Toft, Ninfa Saunders and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot